Search

Subramonia P Pillai

from West Henrietta, NY
Age ~76
Get Report
Also known as:
Subramonia Saroja Pillai, Saroja P Pillai, Padmanabhan S Pillai, Pazhani S Pillai
Related to:
Gowri S Pillai, 39
Connected to:
Ajay Pillai, 34Ajikumar N Pillai, 52Aleta A Pillai, 55Aravind Pillai, 71Archana Pillai, 45Ashok P Pillai, 63Athira PillaiDamodaran G Pillai, 61Deepti K Pillai, 44Devika Pillai, 72

Subramonia Pillai Phones & Addresses

  • West Henrietta, NY
  • Henrietta, NY
  • 237 Catamount Rd, Tewksbury, MA 01876 (978) 851-4686
  • 55 Underhill Dr, Pomona, NY 10970 (845) 371-7033
  • 422 Avalon Gardens Dr, Nanuet, NY 10954 (845) 371-7033
  • Pittsford, NY
  • Rochester, NY
  • 55 Underhill Dr, Pomona, NY 10970

Work

Position: Professional/Technical

Publications

Us Patents

Polysaccharide-Staphylococcal Surface Adhesin Carrier Protein Conjugates For Immunization Against Nosocomial Infections

View page
US Patent:
8377451, Feb 19, 2013
Filed:
Nov 7, 2006
Appl. No.:
11/593481
Inventors:
Viliam Pavliak - Montebello NY, US
Steven Morris Baker - Highland Mills NY, US
Subramonia Padmanaba Pillai - Pomona NY, US
Joseph M. Patti - Cumming GA, US
Bradley D. Prater - Atlanta GA, US
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
A61K 39/02
US Classification:
4242341
Abstract:
Immunogenic polysaccharide-protein conjugates having a polysaccharide antigen (or its oligosaccharide fragment representing one or more antigenic epitopes) derived from a nosocomial pathogen conjugated to a staphylococcal surface adhesin carrier protein are used in immunogenic compositions to elicit antibody responses to both the polysaccharide antigen and the staphylococcal surface adhesin carrier protein. Such immunogenic compositions are used to immunize against diseases caused by or other nosocomial pathogens.

Polysaccharide-Staphylococcal Surface Adhesin Carrier Protein Conjugates For Immunization Against Nosocomial Infections

View page
US Patent:
20070087014, Apr 19, 2007
Filed:
Mar 4, 2004
Appl. No.:
10/548507
Inventors:
Viliam Pavliak - Montebello NY, US
Steven Baker - Highland Mills NY, US
Subramonia Pillai - Pomona NY, US
Joseph Patti - Cumming GA, US
Bradley Prater - Atlanta GA, US
Assignee:
Wyeth - Madison NJ
Inhibitex, Inc. - Alpharetta GA
International Classification:
A61K 39/116
A61K 39/085
C07K 14/31
US Classification:
424203100, 424243100, 530395000
Abstract:
Immunogenic polysaccharide-protein conjugates having a polysaccharide antigen (or its oligosaccharide fragment representing one or more antigenic epitopes) derived from a nosocomial pathogen conjugated to a staphylococcal surface adhesin carrier protein are used in immunogenic compositions to elicit antibody responses to both the polysaccharide antigen and the staphylococcal surface adhesion carrier protein. Such immunogenic compositions are used to immunize against diseases caused by or other nosocomial pathogens.

Vaccines For The Malaria Circumsporozoite Protein

View page
US Patent:
51127490, May 12, 1992
Filed:
Oct 2, 1987
Appl. No.:
7/104735
Inventors:
Robert N. Brey - Rochester NY
William R. Majarian - Pittsford NY
Subramonia Pillai - Rochester NY
Wayne T. Hockmeyer - Pittsford NY
Assignee:
Praxis Biologics, Inc. - Rochester NY
International Classification:
C12N 1500
C12N 121
C12N 100
C12P 2102
A01N 6300
C07H 1512
C07K 300
US Classification:
4351723
Abstract:
The present invention is directed to attenuated strains of enteroinvasive bacteria that express a peptide or protein related to an epitope of the malaria parasites of the genus Plasmodium. The bacterial strains of the invention which can multiply in a host without causing significant disease or disorder, and which express a Plasmodium-related peptide that induces a protective immune response against malaria, can be used in live vaccine formulations for malaria. In specific embodiments, a Plasmodium-related peptide can be expressed as a fusion protein, for example, with a bacterial enterotoxin. The invention also relates to methods for expression of malaria antigens or fragments thereof within attenuated enteroinvasive bacteria. In particular embodiments, the invention is directed to the expression by attenuated Salmonella spp. of epitopes of Plasmodium circumsporozoite proteins.

Synthetic Peptides Representing A T-Cell Epitope As A Carrier Molecule For Conjugate Vaccines

View page
US Patent:
57859736, Jul 28, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/481923
Inventors:
Garvin Bixler - Fairport NY
Subramonia Pillai - Rochester NY
Richard Insel - Rochester NY
Assignee:
Praxis Biologics, Inc. - Rochester NY
International Classification:
A61K 3912
A61K 3816
A61K 3808
US Classification:
42419611
Abstract:
The present invention relates to novel T-cell epitopes of bacterial products. The epitopes of the invention may be employed in the preparation of conjugates between the epitopes and medically useful antigens, haptens, or antigenic determinants. These conjugates are capable of eliciting antibody responses similar to conjugates of antigens covalently coupled to carrier proteins, and in a vaccine composition, provide a safe and more economic conjugate vaccines.

Cytokine And Hormone Carriers For Conjugate Vaccines

View page
US Patent:
53343794, Aug 2, 1994
Filed:
Jul 16, 1990
Appl. No.:
7/553901
Inventors:
Subramonia Pillai - Rochester NY
Ronald Eby - Rochester NY
Assignee:
American Cyanamid Company - Wayne NJ
International Classification:
A61K 3766
A61K 3902
A61K 39385
C07K 1526
US Classification:
424 852
Abstract:
This invention pertains to immunogenic conjugates comprising a carbohydrate containing antigen or other antigen bound to or genetically fused with a cytokine, lymphokine, hormone or growth factor having immunomodulating activity, wherein the cytokine, lymphokine, hormone or growth factor is capable of modifying immunogenicity of the carbohydrate containing antigen. The cytokine or lymphokine can be an interleukin or an interferon. The immunogenic conjugate can be used in vaccine and co-vaccine formulations.
Control profile
Subramonia P Pillai from West Henrietta, NY, age ~76 Get Report